Inventor
LEE JINHWA
KR30 patents
⚠️ This page may combine multiple inventors who share the name “LEE JINHWA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
1ST BIOTHERAPEUTICS INC
12 patentsUS10385046B1Aug 20, 2019
Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders
1ST BIOTHERAPEUTICS INC4 citations71
US10669246B2Jun 2, 2020
Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
1ST BIOTHERAPEUTICS INC5 citations67
US12534461B2Jan 27, 2026
Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders
1ST BIOTHERAPEUTICS INC0 citations59
US11802126B2Oct 31, 2023
Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders
1ST BIOTHERAPEUTICS INC1 citations59
US11098044B2Aug 24, 2021
Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders
1ST BIOTHERAPEUTICS INC1 citations59
US12509458B2Dec 30, 2025
[18F]-labeled imidazopyridine derivatives as PET radiotracer
1ST BIOTHERAPEUTICS INC0 citations57
US11834467B2Dec 5, 2023
Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors
1ST BIOTHERAPEUTICS INC0 citations56
US11649255B2May 16, 2023
Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same
1ST BIOTHERAPEUTICS INC0 citations56
US10968188B2Apr 6, 2021
Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
1ST BIOTHERAPEUTICS INC1 citations55
US12304905B2May 20, 2025
Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof
1ST BIOTHERAPEUTICS INC0 citations50
US12398156B2Aug 26, 2025
Compounds for prevention or treatment of neurodegenerative disorders
1ST BIOTHERAPEUTICS INC0 citations48
US11744824B2Sep 5, 2023
2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds
1ST BIOTHERAPEUTICS INC0 citations45
LEE JINHWA
8 patentsUS8586550B2Nov 19, 2013
Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same
LEE JINHWA26 citations91
US8541380B2Sep 24, 2013
C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same
LEE JINHWA3 citations60
US8178551B2May 15, 2012
Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatment
LEE JINHWA1 citations49
US8835436B2Sep 16, 2014
Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
LEE JINHWA1 citations48
US9006187B2Apr 14, 2015
Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same
LEE JINHWA0 citations40
US8895558B2Nov 25, 2014
Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
LEE JINHWA0 citations40
US8785453B2Jul 22, 2014
Arylpiperazine-containing purine derivatives and uses thereof
LEE JINHWA0 citations39
US8309584B2Nov 13, 2012
Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonists
LEE JINHWA0 citations39
SMITHKLINE BEECHAM CORP
5 patentsUS6797730B2Sep 28, 2004
Peptide deformylase inhibitors
SMITHKLINE BEECHAM CORP8 citations74
US7442793B2Oct 28, 2008
Peptide deformylase inhibitors
SMITHKLINE BEECHAM CORP2 citations62
US7019003B2Mar 28, 2006
Peptide deformylase inhibitors
SMITHKLINE BEECHAM CORP6 citations60
US7375120B2May 20, 2008
Peptide deformylase inhibitors
SMITHKLINE BEECHAM CORP0 citations41
US7166624B2Jan 23, 2007
Peptide deformylase inhibitors
SMITHKLINE BEECHAM CORP0 citations41